Trestle Biotherapeutics YC 申请

Winter 2021Active

Trestle Biotherapeutics 在 Winter 2021 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Winter 2021
行业: HealthcareIndustrial Bio
团队规模: 2
状态: Active
已发布: 2021

创始人

Ben ShepherdFounder
Alice ChenFounder

Trestle Biotherapeutics 做什么

We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.

Trestle Biotherapeutics 的 YC 申请，重建版

Y Combinator 申请

Trestle Biotherapeutics，Winter 2021 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Trestle Biotherapeutics

Describe what your company does in 50 characters or less.

Bioengineered kidneys for kidney failure

What is your company going to make? Please describe your product and what it does or will do.

We are building an implantable tissue that supplements kidney function for patients with end stage renal disease. Once implanted, it reduces or eliminates their need for dialysis and delays the time until transplantation is necessary.

Where do you live now, and where would the company be based after YC?

We currently live in San Diego, CA. After YC, we plan to keep the company based here to maintain close ties to our research partners and clinical collaborators.

Explain your decision regarding location.

San Diego is a biotech hub with strong academic and clinical resources. Being here lets us work closely with surgeons and researchers to develop an implantable kidney tissue tailored for patients.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Trestle Biotherapeutics 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Trestle Biotherapeutics 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Trestle Biotherapeutics 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Trestle Biotherapeutics 是哪个 YC 批次的？

Trestle Biotherapeutics 是 Y Combinator Winter 2021 批次的成员。

谁创立了 Trestle Biotherapeutics？

Trestle Biotherapeutics 由 Ben Shepherd, Alice Chen 创立。

Trestle Biotherapeutics 做什么？

Bioengineered kidneys for patients with kidney failure

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Trestle Biotherapeutics 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。